Premium
Thalidomide in the treatment of neuro‐Behçet's syndrome
Author(s) -
RAMSELAAR C.G.,
BOONE R.M.,
KLUINNELEMANS H.C.
Publication year - 1986
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1986.tb05753.x
Subject(s) - thalidomide , medicine , prednisolone , chlorambucil , dermatology , behcet's disease , pediatrics , surgery , chemotherapy , disease , cyclophosphamide , multiple myeloma
SUMMARY No relapses of symptoms in a patient with neuro‐Behçet's syndrome were observed after the addition of thalidomide to chlorambucil and prednisolone therapy. At present, the patient has been free of symptoms for 3 years. This observation, together with those reported from the literature, strongly support a re‐evaluation of thalidomide therapy in certain life‐threatening diseases such as neuro‐Behçet's syndrome.